honokiol has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JY; Cha, BY; Hasegawa, S; Nagai, K; Takami, M; Teruya, T; Woo, JT; Yagasaki, K; Yonezawa, T | 1 |
Choi, EM | 1 |
Arbiser, JL; Weitzmann, MN; Yamaguchi, M | 1 |
3 other study(ies) available for honokiol and Bone Loss, Osteoclastic
Article | Year |
---|---|
Honokiol inhibits osteoclast differentiation and function in vitro.
Topics: Acid Phosphatase; Actins; Animals; Biphenyl Compounds; Bone Density Conservation Agents; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Dentin; Isoenzymes; Lignans; Magnolia; Mice; Mitogen-Activated Protein Kinases; NFATC Transcription Factors; Osteoclasts; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-fos; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2010 |
Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators.
Topics: Alkaline Phosphatase; Animals; Antimycin A; Biphenyl Compounds; Bone Resorption; Calcification, Physiologic; Cell Growth Processes; Cell Line; Collagen; Glutathione; Humans; Interleukin-6; Lignans; Magnolia; Mice; Osteoblasts; Osteoporosis; Osteoprotegerin; Phytotherapy; RANK Ligand; Tumor Necrosis Factor-alpha | 2011 |
Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Blotting, Western; Bone Morphogenetic Protein 2; Bone Resorption; Cell Differentiation; Cell Line; Drugs, Chinese Herbal; Humans; Lignans; Magnolia; Mice; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha | 2011 |